ARCH Venture Fund XII, L.P.

ARCH Venture Fund XII, L.P. is 10% Owner at Neumora Therapeutics, Inc. (NMRA). They have made 2 open-market trades across 1 company since 2023, most recently 2023-11-14.

CIK 0001906837

Get an email the next time ARCH Venture Fund XII, L.P. files.Follow for free

2 open-market purchases totalling $2.0M since 2023, never a sale. Too few scored purchases to measure a record yet.

Current Position

Ticker	Shares	Value
PRME	6,230,300	$21.6M
NMRA	4,127,850	$2.0M
Total		$23.6M

Shares reported on the most recent Form 4, priced at the 2025-08-01 close.

Grade by Ticker

BPRME

awaiting returns

Get an email the next time ARCH Venture Fund XII, L.P. files

Free account. One email when the next filing comes in.

Follow ARCH Venture Fund XII, L.P. for free

Buy Track Record

Filings2

Only 2 discretionary filings — too few to score

Discretionary filings only. 10b5-1 plan trades, tax withholding and option exercises are excluded, and each column is one row per filing rather than per execution lot.